Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (5)
- (-) Clean Water (2)
- (-) Cybersecurity (1)
- (-) Environment (10)
- (-) Isotopes (1)
- (-) Materials Science (10)
- (-) Microscopy (1)
- 3-D Printing/Advanced Manufacturing (17)
- Advanced Reactors (1)
- Artificial Intelligence (3)
- Bioenergy (11)
- Biology (1)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (3)
- Composites (2)
- Computer Science (9)
- Coronavirus (7)
- Decarbonization (1)
- Energy Storage (6)
- Exascale Computing (1)
- Grid (2)
- High-Performance Computing (1)
- Machine Learning (3)
- Materials (2)
- Mathematics (1)
- Mercury (1)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (20)
- Nuclear Energy (1)
- Physics (4)
- Polymers (2)
- Quantum Science (2)
- Security (1)
- Summit (5)
- Sustainable Energy (14)
- Transformational Challenge Reactor (2)
- Transportation (8)
Media Contacts
ORNL and The University of Toledo have entered into a memorandum of understanding for collaborative research.
The National Alliance for Water Innovation, a partnership of the Department of Energy’s Oak Ridge National Laboratory, other national labs, university and private sector partners, has been awarded a five-year, $100 million Energy-Water Desalination Hub by DOE to address water security issues in the United States.
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.